Abstract. Fucoidan, a sulfated polysaccharide extracted from brown seaweed, has been used in traditional Chinese herbal medicine to treat thyroid tumors for many years. Although a number of its cellular effects have been investigated, the role of fucoidan in molecular signaling, particularly in Ca 2+ signaling, remains largely unknown. In the present study, the effects of fucoidan on Ca 2+ responses in HeLa cells, human umbilical vein endothelial cells and astrocytes were investigated using a wide range of receptor agonists. Fucoidan inhibited the increase in intracellular free calcium concentration that was induced by histamine, ATP, compound 48/80 and acetylcholine. The responses induced by the same agonists in the absence of extracellular Ca 2+ were also markedly suppressed by fucoidan. Reverse transcription-polymerase chain reaction demonstrated that 0.5 and 1.0 mg/ml fucoidan treatment for 3 h decreased histamine receptor 1 expression in HeLa cells. Similarly, the expressions of purinergic receptor P2Y, G-protein coupled (P2YR)1, P2YR2 and P2YR11 were significantly downregulated within cells pretreated with 1.0 mg/ml fucoidan for 3 h, and 0.5 mg/ml fucoidan significantly inhibited P2YR1 and P2YR11 expression. The results demonstrated that fucoidan may exert a wide spectrum of inhibitory effects on Ca 2+ responses and that fucoidan may inhibit a number of different G-protein coupled receptors associated with Ca 2+ dynamics.
Introduction
Fucoidan is a sulfated polysaccharide extracted from brown seaweed. It has a chain structure similar to that of heparin (1, 2) . It exerts various biological activities including anticoagulation and inhibition of cell proliferation (3) (4) (5) (6) (7) . Fucoidan may have antitumor activity against a variety of tumors, such as leukemia, sarcoma-180, non-small-cell human bronchopulmonary carcinoma (NSCLC-N6), and breast cancer (8) (9) (10) (11) (12) . A double-blind randomized controlled trial showed low-molecular-weight fucoidan combined with chemical agents significantly improved the disease control rate in metastatic colorectal cancer patients (13) . However, little is known about the mechanism underlying these biological activities. Intracellular calcium ions are important second messengers that control a variety of cellular responses (14) . Several newly identified T-type calcium channel blockers have been shown to be able to inhibit the growth of human cancer cells by blocking Ca 2+ influx into the cells (15) , a process that affects cell cycle progression and cell proliferation. These blockers are potential therapeutic agents for the tumors that depend on T-type calcium channel to grow (16) . These studies suggest that calcium signaling may participate in tumorigenesis and targeting their signaling could have therapeutic values.
However, details about the effect of fucoidan on Ca 2+ signaling are largely unknown. In Sertoli cells, fucoidan could activate the Ca 2+ influx regulated by the L-type voltage-operated Ca 2+ channels by serving as an L-selectin ligand (17) . However, the opposite effect of fucoidan on Ca 2+ signaling has also been reported. In polymorphonuclear leukocytes, fucoidan could partly inhibit the oxLDL-induced increase in intracellular calcium concentration [Ca 2+ ] i by serving as a scavenger receptor ligand (18) . Despite the fact that different cell types were used in these studies, and that opposite effects of fucoidan on Ca 2+ signaling were found, these studies commonly demonstrated that both L-selectin receptors and scavenger receptors were sensitive to fucoidan. Also, many tumor cells that do not express L-selectin receptors or the scavenger receptors still exhibit Ca 2+ responses (19) . In HeLa cells, for example, Ca 2+ responses are induced through other receptors (20) (21) (22) (23) 
Materials and methods
Chemicals. Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS), penicillin, streptomycin, and 0.25% trypsin-EGTA (ethylene glycol tetraacetic acid) were purchased from Invitrogen (Thermo Fisher Scientific, Inc., Waltham, MA, USA). Fura-2 acetoxymethyl ester (fura-2/AM) was purchased from Dojindo Laboratories (Kumamoto, Japan). Acetylcholine chloride (ACh) was obtained from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Fucoidan (MW=c.a. 20 kDa), adenosine-5'-triphosphate (ATP), compound 48/80, and histamine were obtained from Sigma-Aldrich (Merck KGaA, Darmstadt, Germany). Heparin was obtained from Ajinomoto Co., Inc. (Tokyo, Japan).
Passage cultures of HeLa cells, astrocytes, and HUVECs.
HeLa cells and astrocytes (a gift from Dr R Susuki, Photon Medical Research Center, Hamamatsu University School of Medicine) were cultured at 37˚C in a humidified atmosphere of 95% air and 5% carbon dioxide (CO 2 ) in DMEM supplemented with 10% FBS and 100 units/ml penicillin-streptomycin. These cells were maintained in 60-mm dishes (Corning Incorporated, Corning, NY, USA). For studies of Ca 2+ response, the cells were subcultured in 35-mm glass-bottom dishes (Iwaki Glass, Chiba, Japan) at approximately 0.5x10 5 cells per dish. Human umbilical vein endothelial cells (HUVECs), purchased from Health Science Research Resources Bank (HSRRB; Osaka, Japan), were maintained in E-STIM Endothelial Cell Culture Medium (BD Biosciences, Franklin Lakes, NJ, USA) with 10% FBS, 10 ng/ml EGF, and 200 µg/ml endothelial cell growth supplements (ECGS) on 75-mm flasks. They were cultured in a humidified incubator containing 5% CO 2 and 95% air at 37˚C. The HUVECs were removed from the substrate with 0.25% trypsin and 0.02% EDTA (BD Biosciences) and passaged on coverslips in 35-mm-diameter culture dishes at a density of 1x10 4 
Reverse transcription-polymerase chain reaction (RT-PCR).
In order to examine the effects of fucoidan on expressions of specific G-protein coupled receptors, RT-PCR was used to identify the mRNA expressions of H1R and P2YRs. HeLa cells were serum-starved for 24 h and treated with 0.5 and 1.0 mg/ml fucoidan respectively, for 3 h. The cells were harvested and extracted with RNA. Total RNA pellet was resolved in 10 µl of diethylpyrocarbonate-treated water, and 1 µg of each RNA sample was used for the RT reaction. RNA samples were reverse-transcribed to cDNA by RT EasyTM II kit (First-strand cDNA for Real-Time PCR) (Foregene Co., Ltd., Chengdu, China). RT-qPCR was conducted by Real Time PCR EasyTM-SYBR-Green I kit (Foregene Co., Ltd.). TaqMan primers and the probe for H1R were listed in Table I . Amplicon size and reaction specificity were confirmed by agarose gel electrophoresis. Identities of the PCR products were verified by sequencing using a genetic analysis system. Semi-quantitive RT-PCR was used to test the P2YRs expressions. cDNA was amplified by PCR using 2X Taq PCR StarMix (GenStar Biosolutions Co., Ltd., Beijing, China) according to the manufacturer's instructions. The conditions consisted of an initial denaturation step at 95˚C for 2 min, followed by 40 cycles of 30 sec denaturation step at 95˚C, 30 sec annealing step at 53.5˚C to 56.5˚C, and 1 min extension step at 72˚C. A final extension step of 5 min at 72˚C was also performed. PCR products were separated by electrophoresis on a 1% agarose gel. All PCR results were derived with cycle number producing a signal in the linear portion of the amplification curve. The primers were designed as presented in Table II . The GAPDH gene was used as the internal standard, and data were expressed as the ratio of H1R mRNA to GAPDH mRNA or P2YRs mRNA to GADPH mRNA, respectively.
Statistical analysis.
For the quantification of Ca 2+ responses, 10-20 cells were analyzed in each observation. All observations were repeated using 3-5 culture dishes. The integrated amplitude of the Ca 2+ response was calculated using an extended baseline for subtraction. Statistical significance was determined by one-way ANOVA followed by Student's t-test, and differences were considered significant at P<0.05.
Results

Effects of fucoidan on Ca
2+ responses induced by histamine in HeLa cells. Histamine (2.5 µM) was applied three times to induce Ca 2+ responses. The first challenge induced a rapid rise in [Ca 2+ ] i followed by a sustained plateau in HeLa cells in the presence of extracellular Ca 2+ (Fig. 1A) . When the cells were superfused with the recording medium containing fucoidan (0.5 mg/ml), the second histamine challenge (in the same medium) was followed, and only a small response was induced, i.e., a small peak with a small or no plateau preceded by a long delay time (Fig. 1A) . The third challenge, which took place after the removal of fucoidan, induced a quite large response (Fig. 1A) , suggesting that the suppressive effect of fucoidan was reversible. The recovery of the responses was observed within 2 min after removal of fucoidan.
A dose-response curve for the suppression of histamine-induced responses was obtained by using different concentrations of fucoidan (Fig. 1B) . In the presence of extracellular Ca 2+ (filled circles), the Ca 2+ responses were gradually suppressed by fucoidan in a dose-dependent manner. The response was completely suppressed at a concentration of 1.5 mg/ml. Similarly, in the absence of extracellular Ca , stimulation with an agonist, such as histamine, depleted intracellular Ca 2+ pool, and thus the second or the third challenge in the same cell always induced a very small or no response at all. Therefore, we compared these responses statistically in the absence or presence of extracellular Ca 2+ by integrating the amplitudes of the first responses induced by the first 3-min challenge only. For the control, we used 3-min applications of agonists after recording the baseline for 3 min. For the test, fucoidan was added to the recording medium during the same baseline period (3 min). Then, without removal of fucoidan, the subsequent doses of agonists were further added to the medium ( Fig. 2A and C) . In both presence and absence of extracellular Ca 2+ , fucoidan at a concentration of 0.5 mg/ml suppressed the Ca 2+ responses induced by histamine very effectively ( Fig. 2B and D) as compared to the control. (Fig. 3A) , and it was suppressed significantly by fucoidan at a concentration of 0.5 mg/ml (Fig. 3A) . The responses induced by compound 48/80 were very sensitive to fucoidan.
Effects of fucoidan on
Effects of fucoidan on Ca
2+ responses induced by cholinergic agonists in HeLa cells. Acetylcholine (ACh) has been shown to act through two major types of receptors, nicotinic and muscarinic receptors. Nicotinic receptors are ligand-gated ion channels (nAChR, also known as ionotropic cholinergic receptors), while muscarinic receptors belong to the G-protein coupled receptor superfamily of seven transmembrane domain proteins (mAChR, also known as metabotropic cholinergic receptors). Our fura-2 Ca 2+ imaging showed that nAChR and mAChR agonists ACh (10 µM) and carbachol (CCh, 10 µM) increased the [Ca 2+ ] i in HeLa cells. Both of these Ca 2+ transients were completely blocked by addition of atropine (10 µM) (Fig. 3B) , a muscarinic antagonist. When fucoidan was applied at 0.5 mg/ml, the ACh-or CCh-induced Ca 2+ responses were suppressed to an extent similar to that of inhibition by atropine (10 µM) (Fig. 3B) . This suppressive effect was reversed immediately after fucoidan was removed from the medium. 
2+ responses induced by histamine in HUVECs and astrocytes. In order to examine the cell specificity of the effects of fucoidan on Ca 2+ responses, we verified the sensitivity of Ca 2+ responses induced by an agonist common to different cell types, specifically HUVECs and astrocytes. Histamine induced Ca 2+ response in HUVECs and astrocytes similar to those induced in HeLa cells. In HUVECs, the Ca 2+ responses induced by histamine (5 µM) were suppressed to approximately 30% the magnitude of the first uninhibited application by the addition of fucoidan at 0.5 mg/ml and to approximately 10% by 1.5 mg/ml (Fig. 3C) . In astrocytes, Ca 2+ responses induced by histamine (10 µM) were reduced to approximately 36 and 6% the magnitude of the first uninhibited application when the cells were given fucoidan at 0.5 and 1.5 mg/ml, respectively (Fig. 3D) , suggesting that histamine receptors expressed both in HUVECs and astrocytes were sensitive to fucoidan in a manner similar to that of HeLa cells.
Effect of heparin on Ca
2+ responses induced by histamine in HeLa cells. Heparin is also a sulfated polysaccharide with a structure similar to that of fucoidan. It has been shown that heparin via micropipette-injection into cells inhibited Ca 2+ responses by inhibiting the inositol 1,4,5-trisphosphate (InsP 3 ) receptor (26, 27) . In our study, heparin was applied extracellularly. Fig. 4 shows a representative single cell trace of [Ca 2+ ] i during a heparin test. In a series of trials, HeLa cells were stimulated first with histamine (2.5 µM) and then superfused with a recording medium containing 40 unit/ml of heparin. Without removal of heparin, the same concentration of histamine (2.5 µM) was re-administered to evaluate the effects of heparin on the Ca 2+ response. By comparing the peak Ca 2+ response induced by histamine in the presence of extracellular Ca 2+ ( Fig. 4A and B) with that in the absence (Fig. 4C and D induced by ATP (5 µM) were also insensitive to heparin (data not shown).
Effects of fucoidan on calcium ions in the medium. As described above, fucoidan showed inhibitory effects on Ca 2+ responses linked to a wide range of receptors. We suspected that the inhibition of Ca 2+ responses by fucoidan would be attributable to one of its physical properties related to interaction with calcium ions. Fucoidan is a sulfated polysaccharide and has many negatively charged sulfate groups. These may chelate positively charged Ca 2+ in the extracellular medium. Assuming that this is the case, the shortage of external Ca 2+ would lead to a reduction or complete loss of Ca 2+ response. Our data, obtained using a Ca 2+ -sensitive electrode (Fig. 5) , show that fucoidan has only a very small effect on the effective concentration of calcium ions in solution. This excluded the possibility that the suppression of Ca 2+ response by fucoidan was due to its effect on Ca 2+ chelating. The biological effects of fucoidan can then be solely attributed to its interactions with membrane proteins. and P2YRs, RT-PCR of H1R, P2YR1, P2YR2, and P2YR11 were performed. H1R expression in HeLa cells treated by 0.5 or 1.0 mg/ml fucoidan for 3 h was significantly lower than that of untreated cells (Fig. 6A) . Consistently, the expressions of P2YR1 and P2YR11 in HeLa cells induced by either 0.5 or 1.0 mg/ml for 3 h were decreased significantly compared with untreated cells. And the expression of P2YR2 was also inhibited by 1.0 mg/ml fucoidan treatment for 3 h compared with that of the untreated cells (Fig. 6B, C and D) . These results suggested that fucoidan suppressed the histamine-induced Ca 2+ response by interacting with the H1 type metabotropic histamine receptors, and inhibited ATP-evoked [Ca 2+ ] i by inhibiting the purinergic G-protein-coupled P2Y receptors.
Effects of fucoidan on expressions of H1R and P2YRs in
Discussion
In this report, we described the effects of fucoidan on intracellular Ca 2+ responses induced by the ligands for various receptors to explore the potentials of direct interactions of fucoidan with these receptors. We showed that irrespective of cell types, fucoidan had an inhibitory effect on increases in [Ca 2+ ] i induced by ligands for different receptors in a dose-dependent manner. Our results demonstrated a dose-dependent pattern of fucoidan suppression on histamine-and ATP-induced Ca 2+ responses. Furthermore, we showed that such inhibitory effects of fucoidan were not affected by the external calcium ions. It has been found that fucoidan interacts with a wide variety of receptors, and more importantly, fucoidan has a large number of sulfate residues, it is unlikely that such molecules could diffuse into the cells. In addition, RT-PCR assay identified that fucoidan inhibits mRNA expressions of various G-protein-coupled receptors H1R and P2YRs. Taken together, our results strongly suggest that fucoidan inhibition of Ca 2+ responses may be due to a direct inhibition of different receptors in different cell types.
Histamine receptors are a class of G-protein-coupled receptors (GPCR) with histamine as their endogenous ligand (28) . HeLa cells display well characterized Ca 2+ responses upon histamine stimulation. Ca 2+ responses should be attributed to activation of metabotropic histamine receptors. Our results showed that the integrated amplitude of Ca 2+ responses was approximately three times larger in the presence of extracellular Ca 2+ than in its absence (Fig. 1B) . Previous studies have shown that histamine evokes an increase in [Ca 2+ ] i , of which the initial transient increase is independent of extracellular Ca 2+ . This is followed by a sustained increase that can be abolished by the removal of extracellular Ca 2+ (29, 30) . Previous studies have also demonstrated that all histamine-induced Ca 2+ responses are completely inhibited by the H1 receptor antagonist pyrilamine but not by cimetidine, an inhibitor of H 2 receptors. It has been suggested that the histamine H1-receptor mediates these responses in HeLa cells (31, 32) .
Histamine liberation from mast cells can be induced by compound 48/80 (33) . This stimulates the metabotropic receptor family. This receptor is also expressed on the plasma membranes of HeLa cells and is very sensitive to fucoidan (Fig. 3A) . Furthermore, mRNA of histamine was significantly inhibited by fucoidan suggesting that fucoidan probably suppressed the histamine-induced Ca 2+ response (Fig. 1B ) by interacting with the H1 type of metabotropic histamine receptors (Fig. 6A) .
Purinergic receptors include ligand-gated P2X receptors and G-protein-coupled P2Y receptors. ATP is a stimulant of both P2X receptors and P2Y receptors (34, 35 ] o =2 mM) (Fig. 1C) . However, this inhibition is partial, suggesting that fucoidan must affect either the P2X or P2Y purinergic receptors but not both. ] o =0 mM) (Fig. 1C) . Fig. 1C shows that fucoidan suppresses ATP-induced responses by inhibiting the metabotropic P2Y but not ionotropic P2X receptors. To further identify whether fucoidan impacts on the metabotropic P2Y receptors or not, RT-PCR was used to verify the effect of fucoidan on the expressions of different subtypes of P2YRs. Consistently with the previous results, both treatments of 0.5 and 1.0 mg/ml fucoidan for 3 h inhibit the expression of P2YR1 and P2YR11 significantly, and 1.0 mg/ml fucoidan treatment for 3 h suppresses the expression of P2YR2, which suggests that fucoidan suppresses the P2YRs expression directly, by which inhibits the ATP-evoked Ca 2+ response (Fig. 6B-D) .
Two main classes of ACh receptors are nAChRs and mAChRs: the former are stimulated by nicotine and ACh, and the latter are stimulated by muscarine and ACh. ACh-induced Ca 2+ responses can be completely blocked by atropine in HeLa cells. Atropine is a competitive antagonist only against Table III . Spectrum of effects induced by fucoidan. (36) .
HeLa cells
We conclude that, in the case of HeLa cells, HUVECs, and astrocytes, Ca 2+ responses induced by histamine, ATP, compound 48/80, and ACh can be abolished by fucoidan through an inhibition of G-protein-coupled receptors. Specifically, the downstream of signal transduction is inhibited at the individual sites of the membrane receptors.
In summary, a broad range of membrane receptors, including metabotropic receptors, are strongly sensitive to fucoidan (Table III) . The following points indicate that fucoidan interacts with the cell membrane by a direct extracellular approach only: i) Fucoidan is a large molecule (approximately 20 kDa). ii) Fucoidan is a negatively charged molecule with many sulfate residues, making diffusion through the cell membrane difficult. iii) The effects of fucoidan appear immediately after application and disappear soon after removal. iv) Fucoidan suppresses endocytosis dramatically, so it could not enter the cell in this way (37) . It is quite reasonable to assume that receptors can be internalized when they are occupied by their own ligand (the cell membrane itself is endocytosed). This is visualized by other researchers in histamine receptors and others. So, probably, there is a feedback mechanism in the cell when the density of receptor proteins in intracellular vesicles or in Golgi apparatus become high, expression of mRNA is reduced.
It is known that heparin is an inhibitor of InsP 3 receptors. Because fucoidan has a structure similar to that of heparin, a function similar to that of heparin (inhibition of intracellular InsP 3 receptor pathway) can be expected to underlie its inhibitory effect. Heparin was tested by direct injection into the cytoplasm to inhibit the release of Ca 2+ from the endoplasmic reticulum (26, 27) . In the present study, we applied heparin extracellularly to HeLa cells without any membrane treatment. Heparin did not show any inhibitory effect on the Ca 2+ responses induced by histamine either in the presence or absence of external Ca 2+ (Fig. 4) . Therefore, the fucoidan effect is very difficult to be explained by assuming that the molecule binds to the InsP 3 receptors located on the endoplasmic reticulum. Fucoidan exerts its inhibitory effects on Ca 2+ responses very fast after its application, and these inhibitory effects are reversed within 3 min of its removal from the medium. These findings also support the idea that fucoidan inhibits receptor proteins to suppress Ca 2+ responses. The present work demonstrates that fucoidan has a wide spectrum of effects, most of them somehow connected to inhibit a Ca 2+ response induced by diverse types of agonists and that these effects occur in a dose-dependent manner.
Inhibition was found to be associated with the inhibitory effects on the activities of G-protein-coupled receptors irrespective of cell types. HeLa cells, HUVECs, and astrocytes showed the similar results. The clinical use of fucoidan must be considered with a great care because it has immediate, strong effects on receptor activity, endocytosis and delayed effects on cell proliferation. The degradation of fucoidan into smaller units can be presumed to reduce these effects (although we did not examine this). When administered orally (and degraded by digestive acids), fucoidan might be less effective. While clinical use by injection or local spray inside the body may yield significant results, but which can be quite unpredictable because of the large number of fucoidan targets.
